Ultrasound-Mediated Gene and Drug Delivery Using a Microbubble-Liposome Particle System
暂无分享,去创建一个
Hakho Lee | Sang Gyu Park | Tae-Jong Yoon | Hak Jong Lee | Hakho Lee | Young-Seok Cho | K. Park | S. Park | Tae-Jong Yoon | Y. I. Kim | Hwangand Jae | Soo-Hong Lee | Young-Seok Cho | Young Il Yoon | Yong-Su Kwon | Hee-Sang Cho | Sun-Hee Heo | Kyeong Soon Park | Seung Il Hwang | Young Il Kim | Hwan Jun Jae | Gook-Jun Ahn | Soo‐Hong Lee | Hee-Sang Cho | Sun‐Hee Heo | Gook-Jun Ahn | Yong-Su Kwon | Hak Jong Lee | S. Hwang
[1] J. Bartlett,et al. Validation of activated caspase‐3 antibody staining as a marker of apoptosis in breast cancer , 2012, Histopathology.
[2] Kishan Dholakia,et al. Membrane disruption by optically controlled microbubble cavitation , 2005 .
[3] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[4] Michiel Postema,et al. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. , 2013, Gene.
[5] Paul A Dayton,et al. The magnitude of radiation force on ultrasound contrast agents. , 2002, The Journal of the Acoustical Society of America.
[6] A. S. Moses,et al. Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.
[7] M. A. Arangoa,et al. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes , 2003, Gene Therapy.
[8] R. Shiu,et al. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. , 1987, Cancer research.
[9] Chih-Kuang Yeh,et al. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[10] H. Shmeeda,et al. Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[12] G. Salvesen,et al. Biochemical Characteristics of Caspases-3, -6, -7, and -8* , 1997, The Journal of Biological Chemistry.
[13] Keon Wook Kang,et al. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells. , 2013, Biochimica et biophysica acta.
[14] Soodabeh Davaran,et al. Liposome: classification, preparation, and applications , 2013, Nanoscale Research Letters.
[15] Hairong Zheng,et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[16] C. Eaves,et al. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. , 2008, Cancer research.
[17] Ralf Seip,et al. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[18] Stephen Meairs,et al. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[19] M. Swihart,et al. Nanotoxicity assessment of quantum dots: from cellular to primate studies. , 2013, Chemical Society reviews.
[20] Hak Soo Choi,et al. Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.
[21] K. Loeb,et al. Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] Mark Borden,et al. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.
[23] S. Wrenn,et al. Acoustically active liposome-nanobubble complexes for enhanced ultrasonic imaging and ultrasound-triggered drug delivery. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[24] Y. Barenholz,et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.
[25] E. Grulke,et al. Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[26] Jianghong Rao,et al. Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. , 2014, Small.
[27] R. Murthy,et al. Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[28] A. Look,et al. The requirement for cyclin D function in tumor maintenance. , 2012, Cancer cell.
[29] N. Hirashima,et al. Synergistic effect of a biosurfactant and protamine on gene transfection efficiency. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] Xiaodong Zhou,et al. Role of Sonography for Implantation and Sequential Evaluation of a VX2 Rabbit Liver Tumor Model , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[31] Theresa M Reineke,et al. Theranostics: combining imaging and therapy. , 2011, Bioconjugate chemistry.
[32] Mark A. Borden,et al. Advances in Ultrasound Mediated Gene Therapy Using Microbubble Contrast Agents , 2012, Theranostics.
[33] Dean Ho,et al. Cancer Nanomedicine: From Drug Delivery to Imaging , 2013, Science Translational Medicine.
[34] H. Ninomiya. The Vascular Bed in the Rabbit Ear: Microangiography and Scanning Electron Microscopy of Vascular Corrosion Casts , 2000, Anatomia, histologia, embryologia.
[35] Yun Zhou,et al. The size of sonoporation pores on the cell membrane , 2008, 2008 IEEE Ultrasonics Symposium.
[36] Kostas Kostarelos,et al. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.
[37] Matthew J Hasik,et al. Evaluation of synthetic phospholipid ultrasound contrast agents. , 2002, Ultrasonics.
[38] R. Jain,et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.
[39] Cheri X Deng,et al. Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.
[40] Samir Mitragotri,et al. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.
[41] S. Choi,et al. Comparison between transauricular and transfemoral arterial access for hepatic artery angiography in a rabbit model. , 2011, Journal of vascular and interventional radiology : JVIR.